EPA Transparency Rule To Move Forward Despite Concerns From Scientists

The EPA's proposed science transparency rule, initially introduced in 2018, aims to ensure that the science used in decision-making is transparent and reproducible. However, it faces significant opposition from the scientific community, who argue that it could disqualify important research due to privacy concerns. The rule could impact future EPA regulations on air pollution and toxic chemicals. Despite opposition from numerous health organizations, EPA administrator Andrew Wheeler defends the rule, promising not to disclose confidential information and plans to issue a supplemental rule.

What was the response of the American Heart Association and the American Medical Association to the proposed rule?

How did EPA administrator Andrew Wheeler defend the proposed rule during his testimony?